| The World’s Most Experienced Commercial Microarray Facility just got bigger |
At Ocimum, we believe that your needs have always defined our priorities. Our growth plan and strategy has been envisioned to cater to changing and growing needs of the research community. We are indebted to our growing list of global customers, who have trusted us over the years, referred us as partners in their R&D efforts. Majority of them return to us and have chosen us as their long term outsourcing partner for their ongoing programs. This has helped us continuously expand our portfolio and offer unique range of integrated solutions.
|
| |
 |
|
|
| Biomarker discovery and validation made easy |
 |
ASCENTA® 3.2
Ocimum Biosolutions has announced the release of ASCENTA 3.2, the latest version of its web-based biomarker discovery and validation tool. ASCENTA 3.2 release now supports Match/X™ functionality, allowing users to identify genes represented on the Human Genome U133 Plus 2.0 array which either share a similar pattern of differential expression with a user-specified input gene, or which show an inverse pattern of regulation relative to that gene of interest. The various pre-configured pair-wise sample set comparisons upon which Match/X analyses are based are listed in the appropriate Content Summary and Differences Report documents. More... |
| |
 | |
 |
|
|
| Biotracker™ - The LIMS for Life Sciences Research |
 |
|
Ocimum Biosolutions has announced the imminent release of Biotracker™ 4.2, R&D Life Science LIMS. Until now, Biotracker was customized to suit the workflow requirements of different types of laboratories, such as biobanking, gene expression, genotyping, sequencing, etc. This latest version of Biotracker is a consolidated system, which supports various workflows used in different life science labs. This version also comes with pre-defined workflow templates for standard processes such as Agilent Gene Expression workflow. More... |
| |
 | |
|
|
|
|